<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34379976</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-5827</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>33</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>Langmuir : the ACS journal of surfaces and colloids</Title>
          <ISOAbbreviation>Langmuir</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine.</ArticleTitle>
        <Pagination>
          <StartPage>10200</StartPage>
          <EndPage>10213</EndPage>
          <MedlinePgn>10200-10213</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.langmuir.1c01689</ELocationID>
        <Abstract>
          <AbstractText>Self-emulsifying drug-delivery systems (SEDDS) have been extensively shown to increase oral absorption of solvation-limited compounds. However, there has been little clinical and commercial use of these formulations, in large part because the demonstrated advantages of SEDDS have been outweighed by our inability to precisely predict drug absorption from SEDDS using current in vitro assays. To overcome this limitation and increase the biological relevancy of in vitro assays, an absorption function can be incorporated using biomimetic membranes. However, the effects that SEDDS have on the integrity of a biomimetic membrane are not known. In this study, a quartz crystal microbalance with dissipation monitoring and total internal reflection fluorescence microscopy were employed as complementary methods to in vitro lipolysis-permeation assays to characterize the interaction of various actively digested SEDDS with a liquescent artificial membrane comprising lecithin in dodecane (LiDo). Observations from surface analysis showed that interactions between the digesting SEDDS and LiDo membrane coincided with inflection points in the digestion profiles. Importantly, no indications of membrane damage could be observed, which was supported by flux profiles of the lipophilic model drug felodipine (FEL) and impermeable marker Lucifer yellow on the basal side of the membrane. There was a correlation between the digestion kinetics of the SEDDS and the flux of FEL, but no clear correlation between solubilization and absorption profiles. Membrane interactions were dependent on the composition of lipids within each SEDDS, with the more digestible lipids leading to more pronounced interactions, but in all cases, the integrity of the membrane was maintained. These insights demonstrate that LiDo membranes are compatible with in vitro lipolysis assays for improving predictions of drug absorption from lipid-based formulations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hedge</LastName>
            <ForeName>Oliver J</ForeName>
            <Initials>OJ</Initials>
            <Identifier Source="ORCID">0000-0002-8196-608X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Uppsala University, 751 23 Uppsala, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Höök</LastName>
            <ForeName>Fredrik</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0003-1994-5015</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Nano and Biophysics, Department of Physics, Chalmers Technical University, 412 96 Gothenburg, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joyce</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3619-7901</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Nano and Biophysics, Department of Physics, Chalmers Technical University, 412 96 Gothenburg, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>UniSA Clinical &amp; Health Sciences, University of South Australia, 5090 Adelaide, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of South Australia, 5090 Adelaide, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bergström</LastName>
            <ForeName>Christel A S</ForeName>
            <Initials>CAS</Initials>
            <Identifier Source="ORCID">0000-0002-8917-2612</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Uppsala University, 751 23 Uppsala, Sweden.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Swedish Drug Delivery Center, Department of Pharmacy, Uppsala University, 751 23 Uppsala, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>08</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Langmuir</MedlineTA>
        <NlmUniqueID>9882736</NlmUniqueID>
        <ISSNLinking>0743-7463</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004655">Emulsions</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D054709">Lecithins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032701" MajorTopicYN="Y">Biomimetics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016503" MajorTopicYN="Y">Drug Delivery Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004655" MajorTopicYN="N">Emulsions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054709" MajorTopicYN="N">Lecithins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no
competing financial interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>20</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34379976</ArticleId>
        <ArticleId IdType="pmc">PMC8388123</ArticleId>
        <ArticleId IdType="doi">10.1021/acs.langmuir.1c01689</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Feeney O. M.; Crum M. F.; McEvoy C. L.; Trevaskis N. L.; Williams H. D.; Pouton C. W.; Charman W. N.; Bergström C. A. S.; Porter C. J. H.
50 Years of Oral
Lipid-Based Formulations: Provenance,
Progress and Future Perspectives. Adv. Drug
Deliv. Rev.
2016, 101, 167–194. 10.1016/j.addr.2016.04.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.addr.2016.04.007</ArticleId>
            <ArticleId IdType="pubmed">27089810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Shea J. P.; Holm R.; O’Driscoll C.
M.; Griffin B. T.
Food for
Thought: Formulating Away the Food Effect - a PEARRL Review. J. Pharm. Pharmacol.
2019, 71, 510–535. 10.1111/jphp.12957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.12957</ArticleId>
            <ArticleId IdType="pubmed">29956330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pouton C. W.
Formulation
of Poorly Water-Soluble Drugs for Oral Administration: Physicochemical
and Physiological Issues and the Lipid Formulation Classification
System. Eur. J. Pharm. Sci.
2006, 29, 278–287. 10.1016/j.ejps.2006.04.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejps.2006.04.016</ArticleId>
            <ArticleId IdType="pubmed">16815001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neslihan
Gursoy R.; Benita S.
Self-Emulsifying Drug Delivery Systems
(SEDDS) for Improved Oral Delivery of Lipophilic Drugs. Biomed. Pharmacother.
2004, 58, 173–182. 10.1016/j.biopha.2004.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2004.02.001</ArticleId>
            <ArticleId IdType="pubmed">15082340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borkar N.; Holm R.; Yang M.; Müllertz A.; Mu H.
In Vivo Evaluation of Lipid-Based
Formulations for Oral Delivery
of Apomorphine and Its Diester Prodrugs. Int.
J. Pharm.
2016, 513, 211–217. 10.1016/j.ijpharm.2016.09.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2016.09.024</ArticleId>
            <ArticleId IdType="pubmed">27615708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alskär L. C.; Parrow A.; Keemink J.; Johansson P.; Abrahamsson B.; Bergström C. A.
S.
Effect of Lipids on
Absorption of Carvedilol in Dogs: Is Coadministration of Lipids as
Efficient as a Lipid-Based Formulation?. J.
Controlled Release
2019, 304, 90–100. 10.1016/j.jconrel.2019.04.038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jconrel.2019.04.038</ArticleId>
            <ArticleId IdType="pubmed">31047962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherniakov I.; Izgelov D.; Barasch D.; Davidson E.; Domb A. J.; Hoffman A.
Piperine-pro-Nanolipospheres
as a Novel Oral Delivery
System of Cannabinoids: Pharmacokinetic Evaluation in Healthy Volunteers
in Comparison to Buccal Spray Administration. J. Controlled Release
2017, 266, 1–7. 10.1016/j.jconrel.2017.09.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jconrel.2017.09.011</ArticleId>
            <ArticleId IdType="pubmed">28890215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherniakov I.; Izgelov D.; Domb A. J.; Hoffman A.
The Effect of Pro NanoLipospheres
(PNL) Formulation Containing Natural Absorption Enhancers on the Oral
Bioavailability of Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol
(CBD) in a Rat Model. Eur. J. Pharm. Sci.
2017, 109, 21–30. 10.1016/j.ejps.2017.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejps.2017.07.003</ArticleId>
            <ArticleId IdType="pubmed">28736128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamboj S.; Sethi S.; Rana V.
Lipid Based
Delivery of Efavirenz:
An Answer to Its Erratic Absorption and Food Effect. Eur. J. Pharm. Sci.
2018, 123, 199–216. 10.1016/j.ejps.2018.07.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejps.2018.07.037</ArticleId>
            <ArticleId IdType="pubmed">30031861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazi M.; Al-Swairi M.; Ahmad A.; Raish M.; Alanazi F. K.; Badran M. M.; Khan A. A.; Alanazi A. M.; Hussain M. D.
Evaluation
of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly
Water-Soluble Talinolol: Preparation, in Vitro and in Vivo Assessment. Front. Pharmacol.
2019, 10, 459.10.3389/fphar.2019.00459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2019.00459</ArticleId>
            <ArticleId IdType="pmc">PMC6507620</ArticleId>
            <ArticleId IdType="pubmed">31118895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koehl N. J.; Holm R.; Kuentz M.; Griffin B. T.
Chase Dosing of
Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in
Rats. Pharm. Res.
2020, 37, 124.10.1007/s11095-020-02841-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11095-020-02841-9</ArticleId>
            <ArticleId IdType="pubmed">32524365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koehl N. J.; Henze L. J.; Kuentz M.; Holm R.; Griffin B. T.
Supersaturated
Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax. Pharmaceutics
2020, 12, 564.10.3390/pharmaceutics12060564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics12060564</ArticleId>
            <ArticleId IdType="pmc">PMC7355533</ArticleId>
            <ArticleId IdType="pubmed">32570753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yen C.-C.; Chang C.-W.; Hsu M.-C.; Wu Y.-T.
Self-Nanoemulsifying
Drug Delivery System for Resveratrol: Enhanced Oral Bioavailability
and Reduced Physical Fatigue in Rats. Int. J.
Mol. Sci.
2017, 18, 1853.10.3390/ijms18091853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18091853</ArticleId>
            <ArticleId IdType="pmc">PMC5618502</ArticleId>
            <ArticleId IdType="pubmed">28841149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra V.; Nayak P.; Yadav N.; Singh M.; Tambuwala M. M.; Aljabali A. A. A.
Orally Administered Self-Emulsifying
Drug Delivery
System in Disease Management: Advancement and Patents. Expet Opin. Drug Deliv.
2021, 18, 315–332. 10.1080/17425247.2021.1856073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17425247.2021.1856073</ArticleId>
            <ArticleId IdType="pubmed">33232184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams H. D.; Sassene P.; Kleberg K.; Bakala-N’Goma J.-C.; Calderone M.; Jannin V.; Igonin A.; Partheil A.; Marchaud D.; Jule E.; Vertommen J.; Maio M.; Blundell R.; Benameur H.; Carrière F.; Müllertz A.; Porter C. J. H.; Pouton C. W.
Toward the Establishment
of Standardized In Vitro Tests for Lipid-Based Formulations, Part
1: Method Parameterization and Comparison of In Vitro Digestion Profiles
Across a Range of Representative Formulations. J. Pharm. Sci.
2012, 101, 3360–3380. 10.1002/jps.23205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jps.23205</ArticleId>
            <ArticleId IdType="pubmed">22644939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vithani K.; Jannin V.; Pouton C. W.; Boyd B. J.
Colloidal Aspects
of Dispersion and Digestion of Self-Dispersing Lipid-Based Formulations
for Poorly Water-Soluble Drugs. Adv. Drug Deliv.
Rev.
2019, 142, 16–34. 10.1016/j.addr.2019.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.addr.2019.01.008</ArticleId>
            <ArticleId IdType="pubmed">30677448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keemink J.; Mårtensson E.; Bergström C. A.
S.
A Lipolysis-Permeation
Setup for Simultaneous Study of Digestion and Absorption in Vitro. Mol. Pharm.
2019, 16, 921–930. 10.1021/acs.molpharmaceut.8b00811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.8b00811</ArticleId>
            <ArticleId IdType="pmc">PMC6437649</ArticleId>
            <ArticleId IdType="pubmed">30628771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedge O. J.; Bergström C. A. S.
Suitability
of Artificial Membranes
in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations. Pharm. Res.
2020, 37, 99.10.1007/s11095-020-02833-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11095-020-02833-9</ArticleId>
            <ArticleId IdType="pmc">PMC7239831</ArticleId>
            <ArticleId IdType="pubmed">32435855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falavigna M.; Brurok S.; Klitgaard M.; Flaten G. E.
Simultaneous Assessment
of in Vitro Lipolysis and Permeation in the Mucus-PVPA Model to Predict
Oral Absorption of a Poorly Water Soluble Drug in SNEDDSs. Int. J. Pharm.
2021, 596, 120258.10.1016/j.ijpharm.2021.120258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2021.120258</ArticleId>
            <ArticleId IdType="pubmed">33486034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klitgaard M.; Müllertz A.; Berthelsen R.
Estimating the Oral Absorption from
Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation
Method. Pharmaceutics
2021, 13, 489.10.3390/pharmaceutics13040489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics13040489</ArticleId>
            <ArticleId IdType="pmc">PMC8065752</ArticleId>
            <ArticleId IdType="pubmed">33918449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avdeef A.; Nielsen P. E.; Du C.
M.. Method and Apparatus
for Improving in Vitro Measurement of Membrane Permeability of Chemical
Compounds. U.S. Patent 7,022,528 B2, April 4, 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Avdeef A.
The Rise of
PAMPA. Expert Opin. Drug Metab. Toxicol.
2005, 1, 325–342. 10.1517/17425255.1.2.325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/17425255.1.2.325</ArticleId>
            <ArticleId IdType="pubmed">16922646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodahl M.; Höök F.; Krozer A.; Brzezinski P.; Kasemo B.
Quartz Crystal Microbalance Setup for Frequency and
-factor Measurements in Gaseous and Liquid Environments. Rev. Sci. Instrum.
1995, 66, 3924–3930. 10.1063/1.1145396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1063/1.1145396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caruso F.; Serizawa T.; Furlong D. N.; Okahata Y.
Quartz Crystal Microbalance
and Surface Plasmon Resonance Study of Surfactant Adsorption onto
Gold and Chromium Oxide Surfaces. Langmuir
1995, 11, 1546–1552. 10.1021/la00005a023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/la00005a023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peters R.; Peters J.; Tews K. H.; Bähr W.
A Microfluorimetric
Study of Translational Diffusion in Erythrocyte Membranes. Biochim. Biophys. Acta Biomembr.
1974, 367, 282–294. 10.1016/0005-2736(74)90085-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0005-2736(74)90085-6</ArticleId>
            <ArticleId IdType="pubmed">4429678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blatt E.; Vaz W. L. C.
The Effects of Ca2+ on Lipid Diffusion. Chem. Phys. Lipids
1986, 41, 183–194. 10.1016/0009-3084(86)90021-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0009-3084(86)90021-6</ArticleId>
            <ArticleId IdType="pubmed">3815620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalb E.; Frey S.; Tamm L. K.
Formation
of Supported Planar Bilayers
by Fusion of Vesicles to Supported Phospholipid Monolayers. Biochim. Biophys. Acta Biomembr.
1992, 1103, 307–316. 10.1016/0005-2736(92)90101-q.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0005-2736(92)90101-q</ArticleId>
            <ArticleId IdType="pubmed">1311950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groves J. T.; Parthasarathy R.; Forstner M. B.
Fluorescence Imaging
of Membrane
Dynamics. Annu. Rev. Biomed. Eng.
2008, 10, 311–338. 10.1146/annurev.bioeng.10.061807.160431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.bioeng.10.061807.160431</ArticleId>
            <ArticleId IdType="pubmed">18429702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baek J. M.; Ryu Y.-S.
Surface Sensitive
Analysis Device Using Model Membrane
and Challenges for Biosensor-Chip. BioChip J.
2020, 14, 110–123. 10.1007/s13206-019-4110-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13206-019-4110-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clifton L. A.; Campbell R. A.; Sebastiani F.; Campos-Terán J.; Gonzalez-Martinez J.
F.; Björklund S.; Sotres J.; Cárdenas M.
Design and
Use of Model Membranes to Study Biomolecular Interactions Using Complementary
Surface-Sensitive Techniques. Adv. Colloid Interface
Sci.
2020, 277, 102118.10.1016/j.cis.2020.102118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cis.2020.102118</ArticleId>
            <ArticleId IdType="pubmed">32044469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffin B. T.; Kuentz M.; Vertzoni M.; Kostewicz E. S.; Fei Y.; Faisal W.; Stillhart C.; O’Driscoll C. M.; Reppas C.; Dressman J. B.
Comparison of in
Vitro Tests at Various
Levels of Complexity for the Prediction of in Vivo Performance of
Lipid-Based Formulations: Case Studies with Fenofibrate. Eur. J. Pharm. Biopharm.
2014, 86, 427–437. 10.1016/j.ejpb.2013.10.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejpb.2013.10.016</ArticleId>
            <ArticleId IdType="pubmed">24184675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacchetti M.; Nejati E.
Prediction of Drug Solubility in
Lipid Mixtures from
the Individual Ingredients. AAPS PharmSciTech
2012, 13, 1103–1109. 10.1208/s12249-012-9830-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12249-012-9830-3</ArticleId>
            <ArticleId IdType="pmc">PMC3513432</ArticleId>
            <ArticleId IdType="pubmed">22907779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alskär L. C.; Porter C. J. H.; Bergström C. A.
S.
Tools for Early Prediction
of Drug Loading in Lipid-Based Formulations. Mol. Pharm.
2016, 13, 251–261. 10.1021/acs.molpharmaceut.5b00704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.5b00704</ArticleId>
            <ArticleId IdType="pmc">PMC4928820</ArticleId>
            <ArticleId IdType="pubmed">26568134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mudie D. M.; Murray K.; Hoad C. L.; Pritchard S. E.; Garnett M. C.; Amidon G. L.; Gowland P. A.; Spiller R. C.; Amidon G. E.; Marciani L.
Quantification of Gastrointestinal
Liquid Volumes and Distribution Following a 240 ML Dose of Water in
the Fasted State. Mol. Pharm.
2014, 11, 3039–3047. 10.1021/mp500210c.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/mp500210c</ArticleId>
            <ArticleId IdType="pubmed">25115349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miret S.; Abrahamse L.; de Groene E. M.
Comparison of in Vitro Models for
the Prediction of Compound Absorption across the Human Intestinal
Mucosa. J. Biomol. Screen
2004, 9, 598–606. 10.1177/1087057104267162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1087057104267162</ArticleId>
            <ArticleId IdType="pubmed">15475479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt A.; Karas M.; Dülcks T.
Effect of
Different Solution Flow
Rates on Analyte Ion Signals in Nano-ESI MS, or: When Does ESI Turn
into Nano-ESI?. J. Am. Soc. Mass Spectrom.
2003, 14, 492–500. 10.1016/s1044-0305(03)00128-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1044-0305(03)00128-4</ArticleId>
            <ArticleId IdType="pubmed">12745218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kole P. L.; Venkatesh G.; Kotecha J.; Sheshala R.
Recent Advances in
Sample Preparation Techniques for Effective Bioanalytical Methods. Biomed. Chromatogr.
2011, 25, 199–217. 10.1002/bmc.1560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bmc.1560</ArticleId>
            <ArticleId IdType="pubmed">21154887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez S.; Jannin V.; Rodier J.-D.; Ritter N.; Mahler B.; Carrière F.
Comparative
Study on Digestive Lipase Activities on
the Self Emulsifying Excipient Labrasol, Medium Chain Glycerides and
PEG Esters. Biochim. Biophys. Acta Mol. Cell
Biol. Lipids
2007, 1771, 633–640. 10.1016/j.bbalip.2007.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbalip.2007.02.009</ArticleId>
            <ArticleId IdType="pubmed">17418634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borgström B.
Influence
of Bile Salt, PH, and Time on the Action of Pancreatic Lipase; Physiological
Implications. J. Lipid Res.
1964, 5, 522–531. 10.1016/s0022-2275(20)40179-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0022-2275(20)40179-8</ArticleId>
            <ArticleId IdType="pubmed">14221095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullen M.; Euler W. B.
The Influence of Interfacial Effects
on the Photophysics
of Rhodamine 6G Thin Films on a Poly(Vinylidene Fluoride) Surface. Langmuir
2017, 33, 2194–2204. 10.1021/acs.langmuir.7b00144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.langmuir.7b00144</ArticleId>
            <ArticleId IdType="pubmed">28195482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jönsson P.; Jonsson M. P.; Tegenfeldt J. O.; Höök F.
A Method Improving
the Accuracy of Fluorescence Recovery after Photobleaching Analysis. Biophys. J.
2008, 95, 5334–5348. 10.1529/biophysj.108.134874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1529/biophysj.108.134874</ArticleId>
            <ArticleId IdType="pmc">PMC2586554</ArticleId>
            <ArticleId IdType="pubmed">18567628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US
Department of Agriculture,
Agricultural Research Service Oil, olive, extra light. https://fdc.nal.usda.gov/fdc-app.html#/food-details/1750351/nutrients (accessed 21 04 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>US Department of Agriculture,
Agricultural Research Service Oil, soybean. https://fdc.nal.usda.gov/fdc-app.html#/food-details/748366/nutrients (accessed 21 04 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Lawson D.
M.; Brzozowski A. M.; Dodson G.
Lifting the Lid off Lipases. Curr. Biol.
1992, 2, 473–475.</Citation>
        </Reference>
        <Reference>
          <Citation>Kabedev A.; Hossain S.; Hubert M.; Larsson P.; Bergström C. A.
S.
Molecular
Dynamics Simulations Reveal Membrane Interactions for Poorly Water-Soluble
Drugs: Impact of Bile Solubilization and Drug Aggregation. J. Pharm. Sci.
2021, 110, 176–185. 10.1016/j.xphs.2020.10.061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.xphs.2020.10.061</ArticleId>
            <ArticleId IdType="pubmed">33152373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T. Y.; Liu M.; Portincasa P.; Wang D. Q.-H.
New Insights into the Molecular Mechanism
of Intestinal Fatty Acid Absorption. Eur. J.
Clin. Invest.
2013, 43, 1203–1223. 10.1111/eci.12161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/eci.12161</ArticleId>
            <ArticleId IdType="pmc">PMC3996833</ArticleId>
            <ArticleId IdType="pubmed">24102389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sassene P.; Kleberg K.; Williams H. D.; Bakala-N’Goma J.-C.; Carrière F.; Calderone M.; Jannin V.; Igonin A.; Partheil A.; Marchaud D.; Jule E.; Vertommen J.; Maio M.; Blundell R.; Benameur H.; Porter C. J. H.; Pouton C. W.; Müllertz A.
Toward the Establishment of Standardized
In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying
Pancreatin and Calcium Levels. AAPS J.
2014, 16, 1344–1357. 10.1208/s12248-014-9672-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12248-014-9672-x</ArticleId>
            <ArticleId IdType="pmc">PMC4389749</ArticleId>
            <ArticleId IdType="pubmed">25274609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Dwyer P. J.; Box K. J.; Koehl N. J.; Bennett-Lenane H.; Reppas C.; Holm R.; Kuentz M.; Griffin B. T.
Novel Biphasic
Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations. Mol. Pharm.
2020, 17, 3342–3352. 10.1021/acs.molpharmaceut.0c00427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.0c00427</ArticleId>
            <ArticleId IdType="pubmed">32787274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armand M.; Borel P.; Pasquier B.; Dubois C.; Senft M.; Andre M.; Peyrot J.; Salducci J.; Lairon D.
Physicochemical
Characteristics of Emulsions during Fat Digestion in Human Stomach
and Duodenum. Am. J. Physiol. Gastrointest.
Liver Physiol.
1996, 271, G172–G183. 10.1152/ajpgi.1996.271.1.g172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.1996.271.1.g172</ArticleId>
            <ArticleId IdType="pubmed">8760121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phan S.; Hawley A.; Mulet X.; Waddington L.; Prestidge C. A.; Boyd B. J.
Structural Aspects
of Digestion of
Medium Chain Triglycerides Studied in Real Time Using SSAXS and Cryo-TEM. Pharm. Res.
2013, 30, 3088–3100. 10.1007/s11095-013-1108-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11095-013-1108-2</ArticleId>
            <ArticleId IdType="pubmed">23921485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hossain S.; Joyce P.; Parrow A.; Jõemetsa S.; Höök F.; Larsson P.; Bergström C. A. S.
Influence
of Bile Composition on Membrane Incorporation of Transient Permeability
Enhancers. Mol. Pharm.
2020, 17, 4226–4240. 10.1021/acs.molpharmaceut.0c00668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.0c00668</ArticleId>
            <ArticleId IdType="pmc">PMC7610231</ArticleId>
            <ArticleId IdType="pubmed">32960068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isaksson S.; Watkins E. B.; Browning K. L.; Kjellerup Lind T.; Cárdenas M.; Hedfalk K.; Höök F.; Andersson M.
Protein-Containing Lipid Bilayers Intercalated with
Size-Matched Mesoporous Silica Thin Films. Nano
Lett.
2017, 17, 476–485. 10.1021/acs.nanolett.6b04493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.nanolett.6b04493</ArticleId>
            <ArticleId IdType="pubmed">28073257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pace H. P.; Hannestad J. K.; Armonious A.; Adamo M.; Agnarsson B.; Gunnarsson A.; Micciulla S.; Sjövall P.; Gerelli Y.; Höök F.
Structure and Composition of Native
Membrane Derived Polymer-Supported Lipid Bilayers. Anal. Chem.
2018, 90, 13065–13072. 10.1021/acs.analchem.8b04110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.analchem.8b04110</ArticleId>
            <ArticleId IdType="pubmed">30350611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson N. L.; Burghardt T. P.; Axelrod D.
Measuring Surface Dynamics of Biomolecules
by Total Internal Reflection Fluorescence with Photobleaching Recovery
or Correlation Spectroscopy. Biophys. J.
1981, 33, 435–454. 10.1016/s0006-3495(81)84905-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0006-3495(81)84905-3</ArticleId>
            <ArticleId IdType="pmc">PMC1327440</ArticleId>
            <ArticleId IdType="pubmed">7225515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joyce P.; Jõemetsa S.; Isaksson S.; Hossain S.; Larsson P.; Bergström C.; Höök F.
TIRF Microscopy-Based Monitoring
of Drug Permeation Across a Lipid Membrane Supported on Mesoporous
Silica. Angew. Chem., Int. Ed.
2021, 60, 2069–2073. 10.1002/anie.202011931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/anie.202011931</ArticleId>
            <ArticleId IdType="pmc">PMC7894553</ArticleId>
            <ArticleId IdType="pubmed">32926534</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
